Outlook for 615 small intestinal neuroendocrine tumor patients: Recurrence risk after surgery and disease-specific survival in advanced disease

#3994

Introduction: Small intestinal neuroendocrine tumors (siNET) are one of the most common neuroendocrine neoplasms. Radical surgery is the only curative treatment.

Aim(s): To investigte the following 3 outcomes in a cohort of siNET patients: 1) Disease specific-survival in the total cohort (group1), 2) recurrence-free survival (RFS) and disease-specific survival after intended radical surgery (group2), 3) Disease specific-survival in patients with unresectable disease or residual tumor after primary resection (group3).

Materials and methods: Single center study including consecutive patients diagnosed from 2000-2020 and followed until death or end of study. Disease-specific survival and RFS were investigated by Cox regression analyses with inclusion of prognostic factors.

Conference:

Presenting Author: Andreassen M

Authors: Slott C, Langer S, Møller S, Krogh J, Klose M,

Keywords: Small intestinal neuroendocrine tumor survival, prognosis, recurrence,